The current outbreak of yellow fever virus (YFV) that is afflicting Brazil since the end of 2016 probably originated from a re-introduction of YFV from endemic areas into the non-endemic Southeastern Brazil. However, the lack of genomic sequences from endemic regions hinders the tracking of YFV’s dissemination routes. We assessed the origin and spread of the ongoing YFV Brazilian outbreak analyzing a new set of YFV strains infecting humans, non-human primates (NHPs) and mosquitoes sampled across five Brazilian states from endemic and non-endemic regions between 2015 and 2018. We found two YFV sub-clade 1E lineages circulating in NHP from Goiás state (GO), resulting from independent viral introductions into the Araguaia tributary river basin: while one strain from 2017 clustered intermingled with Venezuelan YFV strains from 2000, the other YFV strains sampled in 2015 and 2017 clustered with sequences of the current YFV outbreak in the Brazilian Southeastern region (named YFV 2015-2018 lineage), displaying the same molecular signature associated to the current YFV outbreak. After its introduction in GO at around mid-2014, the YFV 2015-2018 lineage followed two paths of dissemination outside GO, originating two major YFV sub-lineages: (1) the YFV MG/ES/RJ sub-lineage spread sequentially from the eastern area of Minas Gerais state to Espírito Santo and then to Rio de Janeiro states, following the Southeast Atlantic basin; (2) the YFV MG/SP sub-lineage spread from the southwestern area of Minas Gerais to the metropolitan region of São Paulo state, following the Paraná basin. These results indicate the ongoing YFV outbreak in Southeastern Brazil originated from a dissemination event from GO almost 2 years before its recognition at the end of 2016. From GO this lineage was introduced in Minas Gerais state at least two times, originating two sub-lineages that followed different routes toward densely populated areas. The spread of YFV outside endemic regions for at least 4 years stresses the imperative importance of the continuous monitoring of YFV to aid decision-making for effective control policies aiming the increase of vaccination coverage to avoid the YFV transmission in densely populated urban centers.
The recent reemergence of yellow fever virus (YFV) in Brazil has raised serious concerns due to the rapid dissemination of the virus in the southeastern region. To better understand YFV genetic diversity and dynamics during the recent outbreak in southeastern Brazil, we generated 18 complete and nearly complete genomes from the peak of the epidemic curve from nonhuman primates (NHPs) and human infected cases across the Espírito Santo and Rio de Janeiro states. Genomic sequencing of 18 YFV genomes revealed the estimated timing, source, and likely routes of yellow fever virus transmission and dispersion during one of the largest outbreaks ever registered in Brazil. We showed that during the recent epidemic, YFV was reintroduced from Minas Gerais to the Espírito Santo and Rio de Janeiro states multiple times between 2016 and 2019. The analysis of data from portable sequencing could identify the corridor of spread of YFV. These findings reinforce the idea that continued genomic surveillance strategies can provide information on virus genetic diversity and transmission dynamics that might assist in understanding arbovirus epidemics. IMPORTANCE Arbovirus infections in Brazil, including yellow fever, dengue, zika, and chikungunya, result in considerable morbidity and mortality and are pressing public health concerns. However, our understanding of these outbreaks is hampered by the limited availability of genomic data. In this study, we investigated the genetic diversity and spatial distribution of YFV during the current outbreak by analyzing genomic data from areas in southeastern Brazil not covered by other previous studies. To gain insights into the routes of YFV introduction and dispersion, we tracked the virus by sequencing YFV genomes sampled from nonhuman primates and infected patients from the southeastern region. Our study provides an understanding of how YFV initiates transmission in new Brazilian regions and illustrates that genomics in the field can augment traditional approaches to infectious disease surveillance and control.
Due to the risk of severe vaccine-associated adverse events, yellow fever vaccination in Brazil is only recommended in areas considered at risk for disease. From September 2008 through June 2009, two outbreaks of yellow fever in previously unvaccinated populations resulted in 21 confirmed cases with 9 deaths (case-fatality, 43%) in the southern state of Rio Grande do Sul and 28 cases with 11 deaths (39%) in Sao Paulo state. Epizootic deaths of non-human primates were reported before and during the outbreak. Over 5.5 million doses of yellow fever vaccine were administered in the two most affected states. Vaccine-associated adverse events were associated with six deaths due to acute viscerotropic disease (0.8 deaths per million doses administered) and 45 cases of acute neurotropic disease (5.6 per million doses administered). Yellow fever vaccine recommendations were revised to include areas in Brazil previously not considered at risk for yellow fever.
Yellow fever (YF) is a viral, vector-borne, haemorrhagic fever endemic in tropical regions of Africa and South America. The vaccine for YF is considered safe and effective, but intervention strategies need to be optimised; one of the tools for this is mathematical modelling. We refine and expand an existing modelling framework for Africa to account for transmission in South America. We fit to YF occurrence and serology data. We then estimate the subnational forces of infection for the entire endemic region. Finally, using demographic and vaccination data, we examine the impact of vaccination activities. We estimate that there were 109,000 (95% credible interval [CrI] [67,000–173,000]) severe infections and 51,000 (95% CrI [31,000–82,000]) deaths due to YF in Africa and South America in 2018. We find that mass vaccination activities in Africa reduced deaths by 47% (95% CrI [10%–77%]). This methodology allows us to evaluate the effectiveness of vaccination and illustrates the need for continued vigilance and surveillance of YF.
A re-emergência da febre amarela (FA) fora da região amazônica a partir de 2007 reacendeu a preocupação das autoridades de saúde com a expansão das áreas de circulação viral no Brasil, documentada durante a última década.As áreas mais recentemente atingidas nas regiões sudeste e sul do país, são objetos de destaque em virtude da proximidade com grandes centros urbanos densamente povoados, cuja população não era vacinada, conseqüentemente, com estimativa reduzida de cobertura vacinal. Em diversos grandes centros urbanos dessas regiões, destaca-se a infestação por Aedes aegypti, onde diversos municípios enfrentam períodos de elevada transmissão, sucessivos, para a dengue. Essa realidade trouxe à tona a discussão sobre o risco da retomada da forma de transmissão urbana (por Aedes aegypti) no Brasil. Na última década, entre 2000 e 2010 -dados atualizados até a semana epidemiológica 47 (21/11/2010) -, foram registrados 324 casos humanos confirmados por febre amarela silvestre (FAS), com 155 óbitos (letalidade de 47,8%). Entre os casos registrados, 261 (80,6%) tiveram local provável de infecção (LPI) em área fora da região amazônica, ressaltando a característica da expansão das áreas de ocorrência da febre amarela no Brasil, além da região amazônica.A tendência de expansão da área de risco para a febre amarela no Brasil suscitou a adoção de novas estratégias de vigilância, prevenção e controle. Algumas definições foram revisadas, assim como uma série de atividades dos diferentes eixos de vigilância (casos humanos, epizootias, entomologia, laboratório, imunização e comunicação), visando aprimorar o sistema no sentido de melhor atender aos objetivos propostos.Dentre as inovações atribuídas ao programa de vigilância, prevenção e controle da febre amarela, destaca-se a estratégia atualmente utilizada, a partir da definição de três períodos epidemiológicos distintos, sobretudo para
Autotomy, the strategy of voluntarily releasing a leg during an encounter with a potential predator or in agonistic interactions between conspecifics, is common in animals. The potential costs of this behavior have been scarcely studied. In addition, locomotion and substrate-dependent performance might be affected by autotomy. We did a comparative and observational study to investigate whether losing legs affects the escape speed and trajectory of harvestmen in the genus Prionostemma Pocock, 1903 (Eupnoi: Sclerosomatidae) on different substrates: soil (the least roughened), smooth bark and mossy bark (the most roughened) in a tropical premontane forest in Costa Rica. We observed that 71% of the individuals found were missing at least one leg. Harvestmen, regardless of leg condition, walked faster and made fewer turns in their trajectory in the soil. While climbing, they were faster on smooth bark than in moss. On all substrates, autotomized individuals were slower and had a more erratic trajectory than intact ones. The type of missing legs (sensory or locomotor) had no influence on the speed or trajectory. We experimentally induced autotomy and found that walking speed on soil decreases if individuals lose a leg. Our findings confirm that losing legs affects locomotion, and we provide novel insights on how locomotion in these harvestmen depends on surface roughness. Our data suggest that moss could be a type of substrate that requires more elaborate skills in balance, orientation and texture recognition than smooth bark.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
334 Leonard St
Brooklyn, NY 11211
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.